Lavistral forte

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.Е.005665.11.16
Date of registration and renewal:29.11.2016
Dosage form: & nbspCapsules of 350.0 mg
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Classification "Clinical" & nbsp Supplements containing zinc, copper, manganese Supplements containing iron Supplements containing iodine
Composition: & nbspMicrocrystalline cellulose, mineral premix (calcium carbonate, potassium chloride, magnesium oxide, iron sulfate, potassium iodate, sodium selenite, zinc oxide, copper sulfate, manganese sulfate), eurycoma root extract, althea root extract, goji berries extract, herb extract epimedium), orange extract (synephrine), lycopene, yohimbe bark extract, calcium stearate, silicon dioxide, rhizome extract with leuzea roots, gelatin (capsule).
Scope: & nbspTo realize the population as a biologically active food additive - an additional source of mineral substances (iron, zinc, iodine, selenium, copper and manganese), a source of cinephrine and lycopene containing yohimbine.
Suggested Usage: & nbspAdults take 1 capsule 2 times a day with meals in the morning. Duration of admission is 2-3 weeks. If necessary, the reception can be repeated in a month.
Contraindications:Individual intolerance of the components, pregnancy, breast-feeding, increased nervous excitability, insomnia, high blood pressure, severe atherosclerosis, marked violations of the liver and kidneys,with cardiovascular diseases, with adrenomimetic treatment, reception in the evening. Before use, it is recommended to consult a doctor. Persons with thyroid disease are advised to consult an endocrinologist.
Shelf life:2 years.
Storage conditions:Store in a dry place, protected from direct sunlight, out of reach of children, at a temperature of no higher than 25 ° C.
Research protocols:Expert conclusion of the FBUC of the Federal Target Program and the Federal Service for Consumer Rights Protection No. 10-2FTS / 3274 of 24.11.2016.
Recipient:ComFarm, LLCComFarm, LLC Russian Federation
Information update date: & nbsp14.01.2017
Instructions
Up